While MetAP2 inhibitors generally alleviate multiple pathological conditions, the therapeutic potential of MetAP2 inhibitors in brain disorders has had limited studies despite the abundant presence of MetAP2 in the brain [18]. The gene discussed is METAP2; the disease is brain disorder.